StockData
Cencora, Inc. logo

Cencora, Inc. (COR) stock

CORNYSEWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 14/3021% above fair value
$348.31−2.25 (-0.64%)

Close on Nov 18, 2026Market cap $66.47BP/E 25.9Yield 0.63%

Cencora free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Cencora's free cash flow for the twelve months ending Jun 30, 2026 was $4.06B, up 255.7% year over year. For fiscal 2025 it was $3.21B, up 7.0% from the year before. Over ten years it grew -1.4% a year on average. The highest annual figure on record is $3.69B in fiscal 2015.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Sep 30, 2025$3.21B+7.0%
FY2024Sep 30, 2024$3.00B-13.2%
FY2023Sep 30, 2023$3.45B+56.5%
FY2022Sep 30, 2022$2.21B-1.0%
FY2021Sep 30, 2021$2.23B+21.3%
FY2020Sep 30, 2020$1.84B-9.7%
FY2019Sep 30, 2019$2.03B+89.2%
FY2018Sep 30, 2018$1.07B+3.6%
FY2017Sep 30, 2017$1.04B-61.8%
FY2016Sep 30, 2016$2.71B-26.5%
FY2015Sep 30, 2015$3.69B+207.5%
FY2014Sep 30, 2014$1.20B+104.9%
FY2013Sep 30, 2013$585.68M-50.0%
FY2012Sep 30, 2012$1.17B+15.8%
FY2011Sep 30, 2011$1.01B+8.5%
FY2010Sep 30, 2010$932.15M+46.1%
FY2009Sep 30, 2009$637.93M+6.4%
FY2008Sep 30, 2008$599.76M-45.3%
FY2007Sep 30, 2007$1.10B–

Quarterly free cash flow

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q3 FY2026CQ2 2026Jun 30, 2026$2.43B–
Q2 FY2026CQ1 2026Mar 31, 2026$1.17B-63.6%
Q1 FY2026CQ4 2025Dec 31, 2025-$2.42B–
Q4 FY2025CQ3 2025Sep 30, 2025$2.88B+252.5%
Q3 FY2025CQ2 2025Jun 30, 2025-$73.97M-103.1%
Q2 FY2025CQ1 2025Mar 31, 2025$3.22B–
Q1 FY2025CQ4 2024Dec 31, 2024-$2.82B-448.3%
Q4 FY2024CQ3 2024Sep 30, 2024$818.06M-50.5%
Q3 FY2024CQ2 2024Jun 30, 2024$2.36B+268.3%
Q2 FY2024CQ1 2024Mar 31, 2024-$991.20M-288.2%
Q1 FY2024CQ4 2023Dec 31, 2023$810.94M+27.8%
Q4 FY2023CQ3 2023Sep 30, 2023$1.65B+66.7%
Q3 FY2023CQ2 2023Jun 30, 2023$640.65M+117.0%
Q2 FY2023CQ1 2023Mar 31, 2023$526.65M+284.6%
Q1 FY2023CQ4 2022Dec 31, 2022$634.35M-19.1%
Q4 FY2022CQ3 2022Sep 30, 2022$990.88M+17.3%
Q3 FY2022CQ2 2022Jun 30, 2022$295.23M-72.8%
Q2 FY2022CQ1 2022Mar 31, 2022$136.93M–
Q1 FY2022CQ4 2021Dec 31, 2021$783.72M-6.4%
Q4 FY2021CQ3 2021Sep 30, 2021$845.01M-28.4%
Q3 FY2021CQ2 2021Jun 30, 2021$1.09B–
Q2 FY2021CQ1 2021Mar 31, 2021-$540.11M-169.6%
Q1 FY2021CQ4 2020Dec 31, 2020$837.64M+1009.4%
Q4 FY2020CQ3 2020Sep 30, 2020$1.18B+99.0%
Q3 FY2020CQ2 2020Jun 30, 2020-$194.62M-139.0%
Q2 FY2020CQ1 2020Mar 31, 2020$775.82M+43.1%
Q1 FY2020CQ4 2019Dec 31, 2019$75.51M-81.1%
Q4 FY2019CQ3 2019Sep 30, 2019$593.37M+2.8%
Q3 FY2019CQ2 2019Jun 30, 2019$498.59M-33.0%
Q2 FY2019CQ1 2019Mar 31, 2019$542.11M–
Q1 FY2019CQ4 2018Dec 31, 2018$399.74M–
Q4 FY2018CQ3 2018Sep 30, 2018$577.29M-55.1%
Q3 FY2018CQ2 2018Jun 30, 2018$743.74M–
Q2 FY2018CQ1 2018Mar 31, 2018-$182.74M-127.1%
Q1 FY2018CQ4 2017Dec 31, 2017-$63.32M–
Q4 FY2017CQ3 2017Sep 30, 2017$1.29B+7.1%
Q3 FY2017CQ2 2017Jun 30, 2017-$353.43M–
Q2 FY2017CQ1 2017Mar 31, 2017$673.32M–
Q1 FY2017CQ4 2016Dec 31, 2016-$567.64M–
Q4 FY2016CQ3 2016Sep 30, 2016$1.20B–

More Cencora figures

See a number that looks wrong?